ArticleFrontiers in immunology2026
Integrated single-cell and transcriptomic profiling identifies machine-learning-based pyroptosis biomarkers in IBD.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pyroptosis, an inflammatory form of programmed cell death, contributes to intestinal inflammation in inflammatory bowel disease (IBD), but the key cell types and regulatory genes remain unclear. Methods: We analyzed single-cell RNA-seq data from intestinal mucosa to assess pyroptosis-related gene expression signatures using AUCell, AddModuleScore, and GSVA. High- and low-pyroptosis cells were compared to identify core genes. Findings were validated in bulk peripheral blood transcriptomic data. Machine learning (LASSO, GBM, SVM, Boruta, Random Forest) identified optimal diagnostic genes, and functional enrichment explored biological roles. Results: Pyroptosis was most active in macrophages, epithelial cells, and neutrophils. Six cell subsets consistently exhibited high pyroptosis. Nineteen core pyroptosis-related genes were identified, 16 of which were upregulated in both mucosal and blood samples. Functional analysis linked these genes to apoptosis and reactive oxygen species pathways. Machine learning highlighted six key diagnostic genes-BASP1, LITAF, NAMPT, PHACTR1, PLAUR, PPIF-with BASP1 showing the strongest performance (AUC = 0.935). Conclusions: Pyroptosis is highly active in specific immune and epithelial cells in IBD. Six identified genes show potential as non-invasive diagnostic biomarkers, offering insights into disease mechanisms and therapeutic targets.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.